The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Several cell-intrinsic alterations have poor prognostic features in human breast cancer, as exemplified by the absence of MAP1LC3B/LC3B (microtubule-associated protein 1 light chain 3 β)-positive puncta in the cytoplasm (which indicates reduced autophagic flux) or the loss of nuclear HMGB1 expression by malignant cells. It is well established that breast cancer is under strong immunosurveillance, as reflected by the fact that scarce infiltration of the malignant lesion by CD8(+) cytotoxic T lymphocytes or comparatively dense infiltration by immunosuppressive cell types (such as FOXP3(+) regulatory T cells or CD68(+) tumor-associated macrophages), resulting in low CD8(+):FOXP3(+) or CD8(+):CD68(+) ratios, has a negative prognostic impact. Here, we reveal the surprising finding that cell-intrinsic features may influence the composition of the immune infiltrate in human breast cancer. Thus, the absence of LC3B puncta is correlated with intratumoral (but not peritumoral) infiltration by fewer CD8(+) cells and more FOXP3(+) or CD68(+) cells, resulting in a major drop in the CD8(+):FOXP3(+) or CD8(+):CD68(+) ratios. Moreover, absence of HMGB1 expression in nuclei correlated with a general drop in all immune effectors, in particular FOXP3(+) and CD68(+) cells, both within the tumor and close to it. Combined analysis of LC3B puncta and HMGB1 expression allowed for improved stratification of patients with respect to the characteristics of their immune infiltrate as well as overall and metastasis-free survival. It can be speculated that blocked autophagy in, or HMGB1 loss from, cancer cells may favor tumor progression due to their negative impact on anticancer immunosurveillance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, in human breast cancer, immunohistochemical detection of disabled autophagy correlates with poor CTL/Treg ratios and dismal prognosis. 161”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [161]
In the citing paper
“In addition, loss of autophagy in the tumor or in the host modulates the intra‐tumoral infiltration of regulatory T (TREG) cells (Ladoire et al, 2016; Poillet‐Perez et al, 2020)”
From Autophagy in major human diseases (2021) · cites this paper as Ladoire et al, 2016
In the citing paper
“and the absence of markers of autophagy (i.e., LC3B) in cancer cells has been correlated to reduced intra‐tumoral infiltration of CTLs (but higher infiltration of TREGs and CD68+ macrophages) and poor prognosis in women with breast cancer (Ladoire et al, 2016).”
From Autophagy in major human diseases (2021) · cites this paper as Ladoire et al, 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474 · cited 1×
“Indeed, it is possible that intracellular stress is communicated to the microenvironment (for instance to attract immune effectors into the tumor bed),(36,37) but it is also possible that the immune response against neoplastic cells causes stress response or even the elimination of selective tumor cell populations (im…”
BackgroundInduction of autophagy and inhibition of tumorigenesis by beclin 1
Liang, X. H., Jackson, S., Seaman, M., Brown, K., Kempkes, B., Hibshoosh, H., & Levine, B. (1999) · Nature · doi:10.1038/45257 · Cited by 3,347
Immunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303
Self-citationAutophagy in immunity and inflammation
Levine, B., Mizushima, N., & Virgin, H. W. (2011) · Nature · doi:10.1038/nature09782 · Cited by 3,289
Immunogenic cell death and DAMPs in cancer therapy
Krysko, D. V., Garg, A. D., Kaczmarek, A., Krysko, O., Agostinis, P., & Vandenabeele, P. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3380 · Cited by 3,223
Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056
Self-citationPromotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene
Qu, X., Yu, J., Bhagat, G., Furuya, N., Hibshoosh, H., Troxel, A., Rosen, J., Eskelinen, E.-L., Mizushima, N., Ohsumi, Y., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci20039 · Cited by 2,311
Denkert, C., Loibl, S., Noske, A., Roller, M., Müller, B. M., Komor, M., Budczies, J., Darb-Esfahani, S., Kronenwett, R., Hanusch, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.7370 · Cited by 1,762
DeNardo, D. G., Brennan, D. J., Rexhepaj, E., Ruffell, B., Shiao, S. L., Madden, S. F., Gallagher, W. M., Wadhwani, N., Keil, S. D., Junaid, S. A., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-10-0028 · Cited by 1,715
Loi, S., Sirtaine, N., Piette, F., Salgado, R., Viale, G., Van Eenoo, F., Rouas, G., Francis, P., Crown, J. P. A., Hitre, E., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.0902 · Cited by 1,632
Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
Michaud, M., Martins, I., Sukkurwala, A. Q., Adjemian, S., Ma, Y., Pellegatti, P., Shen, S., Kepp, O., Scoazec, M., Mignot, G., et al. (2011) · Science · doi:10.1126/science.1208347 · Cited by 1,377 · cited 3×
“Similarly, autophagy-deficient colorectal cancers and lung adenocarcinomas fail to elicit protective anticancer immune responses when they are used as vaccines subsequent to their in vitro stimulation with anthracyclines or oxaliplatine.(18) Autophagy-deficient carcinomas and melanomas developing in immunocompetent mi…”
BackgroundInfluentialSelf-citationAdams, S., Gray, R. J., Demaria, S., Goldstein, L., Perez, E. A., Shulman, L. N., Martino, S., Wang, M., Jones, V. E., Saphner, T. J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.55.0491 · Cited by 1,299
Mitochondria and the Autophagy–Inflammation–Cell Death Axis in Organismal Aging
Green, D. R., Galluzzi, L., & Kroemer, G. (2011) · Science · doi:10.1126/science.1201940 · Cited by 1,245
Self-citationAutophagy in malignant transformation and cancer progression
Galluzzi, L., Pietrocola, F., Bravo‐San Pedro, J. M., Amaravadi, R. K., Baehrecke, E. H., Cecconi, F., Codogno, P., Debnath, J., Gewirtz, D. A., Karantza, V., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201490784 · Cited by 1,182 · cited 1×
“The relationship between autophagy and cancer is complex and possibly context-dependent.(1) In the specific case of breast cancer, there is some evidence that inhibition of autophagy may favor oncogenesis and tumor progression.”
BackgroundSelf-citationMetabolic control of autophagy
Galluzzi, L., Pietrocola, F., Levine, B., & Kroemer, G. (2014) · Cell · doi:10.1016/j.cell.2014.11.006 · Cited by 855
Self-citationAutophagy mitigates metabolic stress and genome damage in mammary tumorigenesis
Karantza-Wadsworth, V., Patel, S., Kravchuk, O., Chen, G., Mathew, R., Jin, S., & White, E. (2007) · Genes & Development · doi:10.1101/gad.1565707 · Cited by 841
Ma, Y., Adjemian, S., Mattarollo, S. R., Yamazaki, T., Aymeric, L., Yang, H., Portela Catani, J. P., Hannani, D., Duret, H., Steegh, K., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.03.003 · Cited by 699 · cited 2×
“Autophagy-deficient carcinomas and melanomas developing in immunocompetent mice also fail to attract immune effects upon treatment by chemotherapy or radiotherapy, correlating with markedly reduced treatment responses.(16,18-20)”
BackgroundSelf-citationOn the exact distribution of maximally selected rank statistics
Hothorn, T., & Lausen, B. (2003) · Computational Statistics & Data Analysis · doi:10.1016/s0167-9473(02)00225-6 · Cited by 670 · cited 1×
“To determine adequate cutoff values allowing to patient survival stratification, methods of the martingale residuals for the MFS Cox regression model, and of the log-rank statistics all possible cutpoints, were used.(45)”
MethodMolecular mechanisms of ATP secretion during immunogenic cell death
Martins, I., Wang, Y., Michaud, M., Ma, Y., Sukkurwala, A. Q., Shen, S., Kepp, O., Métivier, D., Galluzzi, L., Perfettini, J.-L., et al. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.75 · Cited by 563
Self-citationLeukocyte composition of human breast cancer
Ruffell, B., Au, A., Rugo, H. S., Esserman, L. J., Hwang, E. S., & Coussens, L. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104303108 · Cited by 479
Dieci, M. V., Criscitiello, C., Goubar, A., Viale, G., Conte, P., Guarneri, V., Ficarra, G., Mathieu, M. C., Delaloge, S., Curigliano, G., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdt556 · Cited by 460
Self-citationChemotherapy-induced antitumor immunity requires formyl peptide receptor 1
Vacchelli, E., Ma, Y., Baracco, E. E., Sistigu, A., Enot, D. P., Pietrocola, F., Yang, H., Adjemian, S., Chaba, K., Semeraro, M., et al. (2015) · Science · doi:10.1126/science.aad0779 · Cited by 452
Self-citationA dual role for autophagy in a murine model of lung cancer
Rao, S., Tortola, L., Perlot, T., Wirnsberger, G., Novatchkova, M., Nitsch, R., Sykacek, P., Frank, L., Schramek, D., Komnenovic, V., et al. (2014) · Nature Communications · doi:10.1038/ncomms4056 · Cited by 442 · cited 5×
“In this model, inhibition of ENTPD1, neutralization of adenosinergic receptors or antibody-mediated depletion of Tregs abolishes the acceleration of oncogenesis induced by Atg5 deletion, underscoring the positive contribution of autophagy to immunosurveillance.(17,40) Figure 4.”
BackgroundMethodInfluentialSelf-citationAn Immunosurveillance Mechanism Controls Cancer Cell Ploidy
Senovilla, L., Vitale, I., Martins, I., Tailler, M., Pailleret, C., Michaud, M., Galluzzi, L., Adjemian, S., Kepp, O., Niso-Santano, M., et al. (2012) · Science · doi:10.1126/science.1224922 · Cited by 436
Self-citationElgendy, M., Sheridan, C., Brumatti, G., & Martin, S. J. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.02.009 · Cited by 426
Dieci, M. V., Mathieu, M. C., Guarneri, V., Conte, P., Delaloge, S., Andre, F., & Goubar, A. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv239 · Cited by 310
Self-citationLadoire, S., Arnould, L., Apetoh, L., Coudert, B., Martin, F., Chauffert, B., Fumoleau, P., & Ghiringhelli, F. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4491 · Cited by 310
Self-citationNatural and therapy-induced immunosurveillance in breast cancer
Kroemer, G., Senovilla, L., Galluzzi, L., André, F., & Zitvogel, L. (2015) · Nature Medicine · doi:10.1038/nm.3944 · Cited by 310 · cited 1×
“Beyond any doubt, local immune responses influence the fate of breast cancer patients.(31)”
BackgroundSelf-citationDefective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists
Yamazaki, T., Hannani, D., Poirier-Colame, V, Ladoire, S., Locher, C., Sistigu, A., Prada, N., Adjemian, S., Catani, J. P., Freudenberg, M., et al. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.72 · Cited by 262 · cited 4×
“cells (in vaccination experiments) or into the tumor (in chemotherapy experiments).(42) Accordingly, tlr4¡/¡ mice are unable to mount an immune response against dying cells, meaning that cancers established on such mice do not respond to chemotherapy or radiotherapy.”
BackgroundMethodInfluentialSelf-citationIn situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival
Ladoire, S., Mignot, G., Dabakuyo, S., Arnould, L., Apetoh, L., Rébé, C., Coudert, B., Martin, F., Bizollon, M. H., Vanoli, A., et al. (2011) · The Journal of Pathology · doi:10.1002/path.2866 · Cited by 226
Self-citationKo, A., Kanehisa, A., Martins, I., Senovilla, L., Chargari, C., Dugue, D., Mariño, G., Kepp, O., Michaud, M., Perfettini, J.-L., et al. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.124 · Cited by 205 · cited 1×
“Similarly, autophagy-deficient tumors (due to transfection with shRNAs targeting Atg5 or Atg7) established in mice release less ATP than their autophagy-competent counterparts when treated with chemotherapy in vivo, fail to attract immune cells into the tumor bed, and do not reduce their growth in response to chemothe…”
BackgroundSelf-citationChaperone-mediated autophagy degrades mutant p53
Vakifahmetoglu-Norberg, H., Kim, M., Xia, H.-G., Iwanicki, M. P., Ofengeim, D., Coloff, J. L., Pan, L., Ince, T. A., Kroemer, G., Brugge, J. S., et al. (2013) · Genes & Development · doi:10.1101/gad.220897.113 · Cited by 203
Self-citationCicchini, M., Chakrabarti, R., Kongara, S., Price, S., Nahar, R., Lozy, F., Zhong, H., Vazquez, A., Kang, Y., & Karantza, V. (2014) · Autophagy · doi:10.4161/auto.34398 · Cited by 153 · cited 1×
“Moreover, in mice, heterozygosity of Becn1, which induces a partial autophagy defect,(4) accelerates breast carcinogenesis in 2 different models, namely in multiparous FVB/N mice, as well as in cooperation with the transgenic expression of theWnt1 oncogene.(5) High expression of the 2 autophagy-relevant proteins ATG5…”
BackgroundGoussetis, D. J., Gounaris, E., Wu, E. J., Vakana, E., Sharma, B., Bogyo, M., Altman, J. K., & Platanias, L. C. (2012) · Blood · doi:10.1182/blood-2012-01-402578 · Cited by 133 · cited 1×
“Autophagy is considered an oncosuppressive phenomenon because it can inhibit a series of cellular phenomena that contribute to oncogenesis,(1) namely the maintenance of a normal cellular metabolism,(9) antimicrobial effects including against oncogenic viruses,(10) maintenance of normal (as opposed to transformed) stem…”
BackgroundTang, H., Sebti, S., Titone, R., Zhou, Y., Isidoro, C., Ross, T. S., Hibshoosh, H., Xiao, G., Packer, M., Xie, Y., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.01.008 · Cited by 128
Ladoire, S., Penault-Llorca, F., Senovilla, L., Dalban, C., Enot, D., Locher, C., Prada, N., Poirier-Colame, V., Chaba, K., Arnould, L., et al. (2015) · Autophagy · doi:10.1080/15548627.2015.1082022 · Cited by 113 · cited 3×
“autophagy and low HMGB1 expression had a particularly poor overall and progression-free survival.(8)”
BackgroundMethodInfluentialSelf-citationMiyashita, M., Sasano, H., Tamaki, K., Chan, M. S. M., Hirakawa, H., Suzuki, A., Tada, H., Watanabe, G., Nemoto, N., Nakagawa, S., et al. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3197-y · Cited by 107
Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy
Stoll, G., Enot, D., Mlecnik, B., Galon, J., Zitvogel, L., & Kroemer, G. (2014) · OncoImmunology · doi:10.4161/onci.27884 · Cited by 88
Self-citationHe, Y., Zhao, X., Subahan, N. R., Fan, L., Gao, J., & Chen, H. (2014) · Tumor Biology · doi:10.1007/s13277-014-2060-4 · Cited by 81
An autophagy-dependent anticancer immune response determines the efficacy of melanoma chemotherapy
Michaud, M., Xie, X., Bravo-San Pedro, J. M., Zitvogel, L., White, E., & Kroemer, G. (2014) · OncoImmunology · doi:10.4161/21624011.2014.944047 · Cited by 80
Self-citationImmunohistochemical detection of cytoplasmic LC3 puncta in human cancer specimens
Ladoire, S., Chaba, K., Martins, I., Sukkurwala, A. Q., Adjemian, S., Michaud, M., Poirier-Colame, V., Andreiuolo, F., Galluzzi, L., White, E., et al. (2012) · Autophagy · doi:10.4161/auto.20353 · Cited by 79 · cited 1×
“LC3B staining We have previously described a validated immunohistochemical protocol for the detection of LC3B puncta in human FFPE cancer specimens.(44) Briefly, immunohistochemical staining of”
MethodSelf-citationRao, S., Yang, H., Penninger, J. M., & Kroemer, G. (2014) · Autophagy · doi:10.4161/auto.27643 · Cited by 63 · cited 1×
“In this model, inhibition of ENTPD1, neutralization of adenosinergic receptors or antibody-mediated depletion of Tregs abolishes the acceleration of oncogenesis induced by Atg5 deletion, underscoring the positive contribution of autophagy to immunosurveillance.(17,40) Figure 4.”
BackgroundSelf-citationDieci, M. V., Criscitiello, C., Goubar, A., Viale, G., Conte, P., Guarneri, V., Ficarra, G., Mathieu, M. C., Delaloge, S., Curigliano, G., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv241 · Cited by 58
Self-citationStoll, G., Bindea, G., Mlecnik, B., Galon, J., Zitvogel, L., & Kroemer, G. (2015) · Oncotarget · doi:10.18632/oncotarget.4180 · Cited by 41
Self-citationWang, L., Yao, L., Zheng, Y.-Z., Xu, Q., Liu, X.-P., Hu, X., Wang, P., & Shao, Z. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.02.037 · Cited by 38 · cited 1×
“High expression of the 2 autophagy-relevant proteins ATG5 and RB1CC1/FIP200 has a positive impact on breast cancer patient survival.(6) Although the absolute expression level of MAP1LC3B/LC3B (microtubule-associated protein 1 light chain 3 b) has no major impact on patient survival,(7) the absence of LC3B puncta, whic…”
BackgroundStoll, G., Zitvogel, L., & Kroemer, G. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1067746 · Cited by 12
Self-citation
Research works printed but not linked: 1
- Dieci MV, Mathieu MC, Guarneri V, Conte P, Delaloge S, Andre F, Goubar A. Prognostic and predictive value of tumor-infiltrating lym- phocytes in two phase III randomized adjuvant breast cancer trials. Ann Oncol 2015; 26:1698-704; PMID:25995301; http://dx.doi.org/ 10.1093/annonc/mdv239 · DOI · Paper page
Cited by
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Galon, J., & Bruni, D. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0007-y · Cited by 3,409
Levy, J. M. M., Towers, C. G., & Thorburn, A. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.53 · Cited by 2,526
The immune contexture in cancer prognosis and treatment
Fridman, W. H., Zitvogel, L., Sautès–Fridman, C., & Kroemer, G. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.101 · Cited by 2,263
Self-citationAutophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
Self-citationImmunogenic cell stress and death
Kroemer, G., Galassi, C., Zitvogel, L., & Galluzzi, L. (2022) · Nature Immunology · doi:10.1038/s41590-022-01132-2 · Cited by 1,353
Self-citation
Metadata
- Authors
- Ladoire, S., Enot, D., Senovilla, L., Ghiringhelli, F., Poirier-Colame, V., Chaba, K., Semeraro, M., Chaix, M., Penault-Llorca, F., Arnould, L., Poillot, M. L., Arveux, P., Delaloge, S., Andre, F., Zitvogel, L., & Kroemer, G.
- Affiliations
- Inserm (FR)
- Institut Gustave Roussy (FR)
- Université Paris-Sud (FR)
- Centre Georges François Leclerc (FR)
- Karolinska University Hospital (SE)
- Corresponding author
- Kroemer, Guido
- ORCID
- Venue
- Autophagy
- Publisher
- Informa UK Limited
- Published
- 2016-03-16
- Volume
- 12
- Issue
- 5
- Pages
- 864-875
- ISSN
- 1554-8627 (ISSN-L)
- 1554-8635
- PMC
- PMC4854557
- OpenAlex
- W2323024458
- Cited by
- 117
- References
- 47
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 11 · 2023: 9 · 2022: 11 · 2021: 12 · 2020: 12 · 2019: 13 · 2018: 15 · 2017: 12 · 2016: 13
- FWCI
- 9.52
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Autophagy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Association pour la Recherche sur le Cancer
- European Commission
- Agence Nationale de la Recherche
- Ligue Contre le Cancer
- Fondation de France
- Institut National Du Cancer
- Institut Gustave-Roussy
- Swiss Bridge Foundation
- Labex Immuno-Oncology
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- breast cancer, HMGB1, tumor immune infiltrate, CD8+ cytotoxic T lymphocytes, Foxp3+ regulatory T cells, CD8/FOXP3 ratio, immune surveillance, prognostic factors, patient stratification, metastasis-free survival
- MeSH terms
- Autophagy, Breast Neoplasms, Female, Humans, Microtubule-Associated Proteins, T-Lymphocytes, Cytotoxic, HMGB1 Protein, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.